
ãã³ãŸãžã¢ãŒãã³ç³»ç¡ç è¬ããæ°èŠè¬å€ãžã®åãæ¿ãïŒã¿ã€ãã³ã°ããã¹ãŠãç ç©¶çµæ
ãã³ãŸãžã¢ãŒãã³å容äœäœåè¬ïŒBZRAïŒã®ç¡ç è¬ãæçšããŠããäœçŸäžäººãã®äººã ã«ãšã£ãŠãããããäžæ¢ããèŠéãã¯æ°ãéããã®ã§ãããããã®è¬å€ã«ã¯ãäžè¬çãªãã³ãŸãžã¢ãŒãã³ç³»è¬å€ãZè¬ãå«ãŸããç¹ã«é·æäœ¿çšã«ãããŠäŸåçãèªç¥æ©èœé害ã転åãåŒãèµ·ããå¯èœæ§ããããŸããã¡ã©ããã³å容äœäœåè¬ããªã¬ãã·ã³åå®¹äœæ®æè¬ãªã©ã®æ°ããã¯ã©ã¹ã®ç¡ç è¬ã¯ãããå®å šãªä»£æ¿è¬ã§ããããããäžå¿çãªèšåºççåã¯æ®ã£ãŠããŸãïŒæ£è ããã§ã«BZRAãæçšããŠããå Žåãæ°èŠã®å¬ç è¬ã远å ãããåãæ¿ãããããããšã§ãå®éã«å€ãè¬å€ãæžããããäžæ¢ãããã§ããã®ã§ããããïŒ Sleep Medicineã«æ²èŒãããæ°ããç ç©¶ã¯ãæç¢ºã§ãããªãããå³ããçããæäŸããŠããŸãã广ã¯ããããæ©æã«è¡åããå Žåã«éãããšãããã®ã§ããæ£è ãBZRAãæçšããŠããæéãé·ããã°é·ãã»ã©ããããæžããããšãé£ãããªããŸãã ãã®ç ç©¶ã¯ã京éœåºç«å»ç§å€§åŠã®ç¶Ÿè°·æ¢ååå£«ãšæ¥æ¬ã®2ã€ã®ç é¢ã®ååããäž»å°ãããã§ã«BZRAå¬ç è¬ãæçšããŠããŠãã®åŸæ°èŠå¬ç è¬ãéå§ãã190äººã®æ£è ã远跡ããŸãããç ç©¶è ãã¯1幎é远跡ããå°ãªããšã1ã€ã®è¬å€ã«ã€ããŠBZRAã®äœ¿çšãæžããããã©ããã確èªããŸããã ç ç©¶çµæ å šäœãšããŠãæ°èŠå¬ç è¬ãéå§ããŠãã1幎以å ã«BZRAã®äœ¿çšãæžããããšã«æåããæ£è ã¯46%ã§ããããããããã®å šäœã®æ°åã¯ãåãæ¿ãåã«æ£è ãBZRAãæçšããŠããæéã«åºã¥ãåçãªå·®ç°ãé ããŠããŸãã BZRAã1å¹Žæªæºäœ¿çšããŠããæ£è ã®å Žåãæåçã¯69%ã§ããããã®ã°ã«ãŒãã®æ£è ã®çŽ10人äž7人ãå€ãè¬å€ãæžããããšãã§ããŸãããBZRAã®ä»¥åã®äœ¿çšã1幎以äžã®æ£è ã§ã¯ãæåçã¯36%ã«äœäžããŸããããã®å·®ã¯çµ±èšçã«éåžžã«ææã§ãããpå€ã¯0.0001æªæºã§ããã ç ç©¶è ãã¯ãã®åŸãå¹Žéœ¢ãæ§å¥ãåŠæ¹ãããå¬ç è¬ã®ç¹å®ã®çš®é¡ãªã©ãçµæã«åœ±é¿ãäžããå¯èœæ§ã®ããä»ã®èŠå ã調æŽããŸããã調æŽåŸã®ãªããºæ¯ã¯ããã«é¡èãªç¶æ³ã瀺ããŠããŸãã宿çãªBZRAã®äºå䜿çšããªãæ£è ãšæ¯èŒããŠã1ã5幎ã®äºå䜿çšãããæ£è ã¯ãæåè£ã®åæžã®ãªããºæ¯ã0.21ïŒ95%ä¿¡é ŒåºéïŒ0.08ã0.56ïŒã§ããã5幎以äžã®äºå䜿çšãããæ£è ã®ãªããºæ¯ã¯0.16ïŒ95% CIïŒ0.06ã0.43ïŒã§ãããå¹³æãªèšèã§èšãã°ãBZRAã1ã5幎æçšããŠããæ£è ã¯ã宿çã«äœ¿çšããŠããªã人ããã䜿çšãæžããããšã«æåããå¯èœæ§ãçŽ5åã®1äœããšããããšã§ãã5幎以äžã§ã¯ããã®ç¢ºçã¯çŽ6åã®1ã«äœäžããŸãã ãã®ç ç©¶ã¯ã2021幎5æãã2022幎4æã®éã«2ã€ã®ç é¢ã§åèš5,114ä»¶ã®å¬ç è¬ãåŠæ¹ããã3,802äººã®æ£è ãšãããã倧ããªããŒã«ããæœåºãããŸããããããã®åŠæ¹ã®ãã¡38%ã¯æ°èŠå¬ç è¬ã§ãããæ°ããè¬å€ã¯ã©ã¹ããã§ã«èšåºçŸå Žã§éèŠãªå²åãå ããŠããããšãæå³ããŸããåæã®å å«åºæºãæºããã190äººã®æ£è ã¯å šå¡ãBZRAãæçšããŠãããç ç©¶æéäžã«æ°èŠå¬ç è¬ãéå§ããŠããŸããã 察象ãšãªã£ãæ°èŠå¬ç è¬ã«ã¯ãäœå ã®èªç¶ãªæŠæ¥çµè·¯ãéããŠç¡ç èŠéãµã€ã¯ã«ã®èª¿æŽãå©ããã¡ã©ããã³å容äœäœåè¬ããè³ã®èŠéä¿é²ã·ã°ãã«ã鮿ããããšã§ç¡ç ãä¿é²ãããªã¬ãã·ã³åå®¹äœæ®æè¬ãå«ãŸããŸããã©ã¡ãã®ã¯ã©ã¹ãBZRAãããå®å šã§ãããšèããããŠãããäŸåãèæ§ãæ¬¡æ¥ã®æ©èœé害ã®ãªã¹ã¯ãäœããªã£ãŠããŸãã éèŠæ§ äžç çã¯ãã©ã€ããªã±ã¢ããã³ç¡ç å»çã«ãããŠæãäžè¬çãªèšŽãã®äžã€ã§ãããBZRAã¯æ°å幎ã«ãããæ²»çã®äž»æµãšãªã£ãŠããŸããããããããã®é·æäœ¿çšã®ãšããã³ã¹ã¯çå®ã«åŒ±ãŸã£ãŠããŸããæ ¢æ§çãªBZRA䜿çšã¯ãèšæ¶éå®³ãæ¥äžã®é®éãé«éœ¢è ã«ããã転åã骚æã®ãªã¹ã¯å¢å ãããã³äžæ¢æã®é¢è±çç¶ã䌎ã身äœçäŸåãšé¢é£ããŠããŸãã ç±³åœç¡ç å»åŠäŒãè±åœç²Ÿç¥è¬çåŠäŒãªã©ã®çµç¹ããã®èšåºã¬ã€ãã©ã€ã³ã¯ãBZRAã®äœ¿çšãçæéïŒå€ãã®å Žå4é±é以å ïŒã«å¶éãããã increasingly æšå¥šããŠããŸããããå®å šãªä»£æ¿è¬ãžã®åãæ¿ãããäžç çã«å¯Ÿããèªç¥è¡åçæ³ãªã©ã®éè¬ç©çæ³ã®äœ¿çšãå§ããŠããŸãã åé¡ã¯ãå®éã«ã¯å€ãã®æ£è ãæ°ã¶æããæ°å¹Žã«ããã£ãŠBZRAã飲ã¿ç¶ããŠããŸãããšã§ããã²ãšãã³ç¿æ £ã確ç«ããããšããããæã¡åãããšã¯éåžžã«å°é£ã§ããæ°ããç ç©¶ã¯ãæ°èŠå¬ç è¬ã®å°å ¥ãBZRAåæžãžã®æ©æž¡ããšãªãåŸãããšã瀺ãããšã§ããã®çŸå®äžçã®èª²é¡ã«çŽæ¥åãçµãã§ããŸãããã ããããã¯æ¯èŒççãæ©äŒã®çªã®äžã§ã®ã¿æå¹ã§ãã èšåºå»ã«ãšã£ãŠã®ã¡ãã»ãŒãžã¯æçœã§ãïŒæ£è ãBZRAãæçšããŠããå Žåã¯ãæ²»çã®æ©ã段éã§æ°èŠå¬ç è¬ã®å°å ¥ãæ€èšããŠãã ãããæ£è ã1幎以äžBZRAãæçšãããŸã§åŸ ã€ãšãå€ãè¬å€ãæžããããšã«æåããå¯èœæ§ã¯åçã«äœäžããŸãã5幎以äžBZRAãæçšããŠããæ£è ã®å ŽåãåçŽãªè¬å€åãæ¿ãã«ããæåã®å¯èœæ§ã¯äœããæŒžæžãšè¡åçæ³ãçµã¿åãããããéäžçãªæŠç¥ãå¿ èŠã«ãªãå ŽåããããŸãã ãããã®çºèŠã¯ãç¡ç å»çã«ãããåŠæ¹é©æ£åïŒdeprescribingïŒã«é¢ããããåºãè°è«ã«ã圱é¿ãäžããŸããäžé©åã«ãªã£ãè¬å€ãäœç³»çã«æžããããäžæ¢ãããããåŠæ¹é©æ£åã®æŠå¿µã¯ãè幎å»åŠã粟ç¥å»åŠã§æ³šç®ãéããŠããŸãããã®ç ç©¶ã¯ãäžçã§æãåºãåŠæ¹ãããŠããè¬å€ã¯ã©ã¹ã®äžã€ã«ã€ããŠããã®è°è«ã«å ·äœçã§å®çšçãªããŒã¿ã远å ããŠããŸãã éç ãã®ç ç©¶ã«ã¯ããã€ãã®éèŠãªéçããããŸããããã¯ã¬ããã¹ãã¯ãã£ããã¶ã€ã³ã§ãããç ç©¶è ã¯æ£è ãç°ãªãæ²»çã«ç¡äœçºã«å²ãä»ããã®ã§ã¯ãªããæ¢åã®å»çèšé²ãåæããããšãæå³ããŸããããã«ããéžæãã€ã¢ã¹ã®å¯èœæ§ãçããŸããæ°èŠå¬ç è¬ãææ¡ãããæ£è ã¯ãææ¡ãããªãã£ãæ£è ãšã¯çµæã«åœ±é¿ãäžããç¹ã§ç°ãªã£ãŠããå¯èœæ§ããããŸãããµã³ãã«ãµã€ãºã¯æ¯èŒçå°ãããå å«åºæºãæºãããæ£è ã¯ããã190人ã§ããããµãã°ã«ãŒãåæã®ç²ŸåºŠãå¶éãããŠããŸãããã®ç ç©¶ã¯æ¥æ¬ã®2ã€ã®ç é¢ã§ã®ã¿å®æœããããããåŠæ¹æ £è¡ãæ£è 人å£çµ±èšãä¿éºé©çšç¯å²ãç°ãªãä»ã®åœãå»çã·ã¹ãã ã«ã¯çµæãäžè¬åã§ããªãå¯èœæ§ããããŸããããã«ãäž»èŠè©äŸ¡é ç®ã¯å°ãªããšã1ã€ã®BZRAè¬å€ã®åæžã§ãããå®å šãªäžæ¢ã§ã¯ãªãã£ããããéšåçãªåæžã®èšåºçæçŸ©ã¯æ£è ããšã«ç°ãªãå¯èœæ§ããããŸãã çµè« ã¡ã©ããã³å容äœäœåè¬ããªã¬ãã·ã³åå®¹äœæ®æè¬ãªã©ã®æ°èŠå¬ç è¬ãå°å ¥ããããšã¯ãæ£è ãå€ãBZRAç¡ç è¬ã®äœ¿çšãæžããã®ã«åœ¹ç«ã¡ãŸãããåãæ¿ãã«æåããããã®çªã¯çãã§ããBZRAã1å¹ŽæªæºæçšããŠããæ£è ã¯çŽ69%ã®ç¢ºçã§äœ¿çšãæžããããšãã§ããŸããã1å¹Žä»¥äžæçšããŠããæ£è ã¯ããã36%ã®ç¢ºçãããããŸããããããã®çµæã¯ãå¯èœãªéãé·æã®BZRAçæ³ãé¿ããèšåºçã«åãæ¿ããå¿ èŠãªå Žåã«ã¯æ©æã«è¡åããŠããå®å šãªä»£æ¿è¬ãå°å ¥ããããšã®éèŠæ§ã匷調ããŠããŸãã é å èš³ Source Ayani N, Matsumoto Y, Kurokawa T, et al. Long-term effects of introducing novel hypnotics to users of benzodiazepine receptor agonist hypnotics. Sleep Med. 2026;147:109148. doi:10.1016/j.sleep.2026.109148. PMID: 42470902.










